141 related articles for article (PubMed ID: 36186486)
1. The clinicopathological significances and related signal pathways of BTG3 mRNA expression in cancers: A bioinformatics analysis.
Zheng HC; Xue H; Zhang CY; Shi KH; Zhang R
Front Genet; 2022; 13():1006582. PubMed ID: 36186486
[TBL] [Abstract][Full Text] [Related]
2. A bioinformatics analysis of the clinicopathological and prognostic significance of
Zheng HC; Ren DH; Zhang CY; Chen Y; Zhang L
J Obstet Gynaecol; 2023 Dec; 43(1):2216280. PubMed ID: 37227120
[TBL] [Abstract][Full Text] [Related]
3. The roles of
Zheng HC; Xue H; Zhang CY; Shi KH; Zhang R
Front Genet; 2022; 13():1006636. PubMed ID: 36339000
[TBL] [Abstract][Full Text] [Related]
4. The bioinformatics analysis of the clinicopathological and prognostic significances of REG4 mRNA in gynecological cancers.
Zhang CY; Zhang L; Wang ZM; Ren DH; Zheng HC
J Obstet Gynaecol; 2023 Dec; 43(1):2213764. PubMed ID: 37218920
[TBL] [Abstract][Full Text] [Related]
5. The clinicopathological and prognostic significances of Dkk3 expression in cancers: A bioinformatics analysis.
Chen GY; Zheng HC
Cancer Biomark; 2018; 23(3):323-331. PubMed ID: 29843219
[TBL] [Abstract][Full Text] [Related]
6. The clinicopathological and prognostic significances of
Zheng HC; Gong BC; Zhao S
Oncotarget; 2017 Nov; 8(56):95270-95279. PubMed ID: 29221126
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of BTG3 was linked to carcinogenesis, aggressiveness, and prognosis of ovarian carcinoma.
Deng B; Zhao Y; Gou W; Chen S; Mao X; Takano Y; Zheng H
Tumour Biol; 2013 Oct; 34(5):2617-24. PubMed ID: 23657964
[TBL] [Abstract][Full Text] [Related]
8. The clinicopathological and prognostic significances of CDC73 expression in breast cancer: A pathological and bioinformatics analysis.
E Y; Xue H; Zhang CY; Zhao MZ; Zheng HC
Histol Histopathol; 2023 Apr; 38(4):453-465. PubMed ID: 36255176
[TBL] [Abstract][Full Text] [Related]
9. Long Non-coding RNA BTG3-7:1 and JUND Co-regulate
Dan Z; Xiujing H; Ting L; Xiaorong Z; Hong Z; Jiqiao Y; Yanchu L; Jing J
Front Mol Biosci; 2020; 7():605623. PubMed ID: 33585557
[TBL] [Abstract][Full Text] [Related]
10. The roles of BTG3 expression in gastric cancer: a potential marker for carcinogenesis and a target molecule for gene therapy.
Gou WF; Yang XF; Shen DF; Zhao S; Liu YP; Sun HZ; Takano Y; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19841-67. PubMed ID: 25904053
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics analysis of the clinicopathological and prognostic significance of BAG3 mRNA in gynecological cancers.
Wang ZM; Zhang L; Ren DH; Zhang CY; Zheng HC
J Obstet Gynaecol; 2023 Dec; 43(2):2228899. PubMed ID: 37377218
[TBL] [Abstract][Full Text] [Related]
12. [Expression of B cell transposition gene 3 in pancreatic ductal adenocarcinoma and its prognostic value].
Chen J; Zhou ZC; Liu WB; Wang J; Chen XJ; Shen YY; Zhong ZX
Zhonghua Wai Ke Za Zhi; 2017 Nov; 55(11):863-867. PubMed ID: 29136736
[No Abstract] [Full Text] [Related]
13. The suppressive role and aberrent promoter methylation of BTG3 in the progression of hepatocellular carcinoma.
Lv Z; Zou H; Peng K; Wang J; Ding Y; Li Y; Ren X; Wang F; Chang R; Liang L; Ding Y
PLoS One; 2013; 8(10):e77473. PubMed ID: 24147003
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatic analysis of the clinicopathological and prognostic significance of oocyte-arresting BTG4 mRNA expression in gynecological cancers.
Zheng HC; Xue H; Zhang CY; Zhang R
J Obstet Gynaecol; 2023 Dec; 43(1):2182672. PubMed ID: 36880525
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of BTG3 promotes cell proliferation, migration and invasion and predicts survival in gastric cancer.
Ren XL; Zhu XH; Li XM; Li YL; Wang JM; Wu PX; Lv ZB; Ma WH; Liao WT; Wang W; Ding YQ; Liang L
J Cancer Res Clin Oncol; 2015 Mar; 141(3):397-405. PubMed ID: 25238703
[TBL] [Abstract][Full Text] [Related]
16. The suppressing effects of BTG3 expression on aggressive behaviors and phenotypes of colorectal cancer: An in vitro and vivo study.
Zheng HC; He HY; Wu JC; Li J; Zhao S; Zhao GF; Jiang HM; Yu XW; Li ZJ
Oncotarget; 2017 Mar; 8(11):18322-18336. PubMed ID: 28407690
[TBL] [Abstract][Full Text] [Related]
17. Expression and prognosis analyses of the Tob/BTG antiproliferative (APRO) protein family in human cancers.
Bai Y; Qiao L; Xie N; Shi Y; Liu N; Wang J
PLoS One; 2017; 12(9):e0184902. PubMed ID: 28922388
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-519c-3p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting BTG3.
Wang L; Mo H; Jiang Y; Wang Y; Sun L; Yao B; Chen T; Liu R; Li Q; Liu Q; Yin G
Biomed Pharmacother; 2019 Oct; 118():109267. PubMed ID: 31387005
[TBL] [Abstract][Full Text] [Related]
19. BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer.
Majid S; Dar AA; Ahmad AE; Hirata H; Kawakami K; Shahryari V; Saini S; Tanaka Y; Dahiya AV; Khatri G; Dahiya R
Carcinogenesis; 2009 Apr; 30(4):662-70. PubMed ID: 19221000
[TBL] [Abstract][Full Text] [Related]
20. Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer.
Majid S; Dar AA; Shahryari V; Hirata H; Ahmad A; Saini S; Tanaka Y; Dahiya AV; Dahiya R
Cancer; 2010 Jan; 116(1):66-76. PubMed ID: 19885928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
